申请人:Boehringer Mannheim GmbH
公开号:US04258058A1
公开(公告)日:1981-03-24
Phenoxyalkylcarboxylic acid compounds of the formula ##STR1## wherein R is hydrogen or lower alkyl R.sub.1 is alkyl or aryl, aralkyl or aralkenyl radical, the aryl moiety of which can be substituted one or more times by halogen, hydroxyl, trifluoromethyl or lower alkyl, alkoxy or acyl R.sub.2 and R.sub.3 are individually selected from hydrogen or lower alkyl, and n is 0, 1, 2 or 3 and the physiologically acceptable salts, esters and amides thereof; are outstandingly effective in inhibiting thrombocyte aggregation.
该公式中的Phenoxyalkylcarboxylic酸化合物,其中R是氢或较低的烷基,R.sub.1是烷基或芳基,芳基可以被卤素、羟基、三氟甲基或较低的烷基、烷氧基或酰基取代一次或多次,R.sub.2和R.sub.3分别选自氢或较低的烷基,n为0、1、2或3,其生理上可接受的盐、酯和酰胺在抑制血小板聚集方面具有出色的效果。